Literature DB >> 32144602

MicroRNA-489-3p Represses Hepatic Stellate Cells Activation by Negatively Regulating the JAG1/Notch3 Signaling Pathway.

Juanjuan Li1, Shouquan Dong1, Mingliang Ye1, Ganjing Peng1, Jie Luo1, Chun Wang1, Jing Wang1, Qiu Zhao1, Ying Chang1, Hongling Wang2,3.   

Abstract

BACKGROUND: The transformation of hepatic stellate cells (HSCs) into collagen-producing myofibroblasts is a key event in hepatic fibrogenesis. Recent studies have shown that microRNAs (miRNAs) play a critical role in the transformation of HSCs. However, the function of miR-489-3p in liver fibrosis remains unclear.
METHODS: Here, we detected the levels of miR-489-3p and jagged canonical Notch ligand 1 (JAG1) in liver fibrosis by using CCl4-treated rats as an in vivo model and transforming growth factor-beta 1 (TGF-β1)-treated HSC cell lines LX-2 and HSC-T6 as in vitro models. The expression of profibrotic markers was affected by transfecting LX-2 cells with either miR-489-3p mimic or si-JAG1. A dual-luciferase reporter assay was carried out to study the interaction of JAG1 with miR-489-3p.
RESULTS: We found that miR-489-3p was remarkably decreased while JAG1 was increased in liver fibrosis models both in vivo and in vitro. Overexpression of miR-489-3p reduced the expression of profibrotic markers and the activation of LX-2 cells induced by TGF-β1. Moreover, miR-489-3p decreased the expression of jagged canonical Notch ligand 1 (JAG1) in LX-2 cells by interacting with its 3'-UTR. As JAG1 is a Notch ligand, decreased JAG1 by miR-489-3p inhibited the Notch signaling pathway. Moreover, the downregulation of JAG1 inhibited the expression of fibrotic markers.
CONCLUSION: Our results indicate that miR-489-3p can inhibit HSC activation by inhibiting the JAG1/Notch3 signaling pathway.

Entities:  

Keywords:  Hepatic stellate cell; JAG1; Liver fibrosis; MiR-489-3p; Notch signaling pathway

Year:  2020        PMID: 32144602     DOI: 10.1007/s10620-020-06174-w

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  25 in total

Review 1.  Hepatic stellate cells and liver fibrosis.

Authors:  Juan E Puche; Yedidya Saiman; Scott L Friedman
Journal:  Compr Physiol       Date:  2013-10       Impact factor: 9.090

Review 2.  Notch in fibrosis and as a target of anti-fibrotic therapy.

Authors:  Biao Hu; Sem H Phan
Journal:  Pharmacol Res       Date:  2016-04-21       Impact factor: 7.658

Review 3.  Mechanisms of hepatic stellate cell activation.

Authors:  Takuma Tsuchida; Scott L Friedman
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-05-10       Impact factor: 46.802

4.  MicroRNA-145-5p regulates fibrotic features of recessive dystrophic epidermolysis bullosa skin fibroblasts.

Authors:  A G Condorelli; E Logli; F Cianfarani; M Teson; A Diociaiuti; M El Hachem; G Zambruno; D Castiglia; T Odorisio
Journal:  Br J Dermatol       Date:  2019-10-20       Impact factor: 9.302

5.  Notch3 regulates the activation of hepatic stellate cells.

Authors:  Yi-Xiong Chen; Zhi-Hong Weng; Shu-Ling Zhang
Journal:  World J Gastroenterol       Date:  2012-03-28       Impact factor: 5.742

Review 6.  Notch Signaling in the Tumor Microenvironment.

Authors:  Olivier Meurette; Patrick Mehlen
Journal:  Cancer Cell       Date:  2018-08-23       Impact factor: 31.743

Review 7.  Developmental signalling pathways in renal fibrosis: the roles of Notch, Wnt and Hedgehog.

Authors:  Maria Edeling; Grace Ragi; Shizheng Huang; Hermann Pavenstädt; Katalin Susztak
Journal:  Nat Rev Nephrol       Date:  2016-05-03       Impact factor: 28.314

Review 8.  Burden of liver disease in Europe: Epidemiology and analysis of risk factors to identify prevention policies.

Authors:  Laura Pimpin; Helena Cortez-Pinto; Francesco Negro; Emily Corbould; Jeffrey V Lazarus; Laura Webber; Nick Sheron
Journal:  J Hepatol       Date:  2018-05-17       Impact factor: 25.083

9.  Inhibition of Notch signaling by a γ-secretase inhibitor attenuates hepatic fibrosis in rats.

Authors:  Yixiong Chen; Shaoping Zheng; Dan Qi; Shaojiang Zheng; Junli Guo; Shuling Zhang; Zhihong Weng
Journal:  PLoS One       Date:  2012-10-03       Impact factor: 3.240

Review 10.  Mechanisms Underlying Cell Therapy in Liver Fibrosis: An Overview.

Authors:  Daphne Pinheiro; Isabelle Dias; Karina Ribeiro Silva; Ana Carolina Stumbo; Alessandra Thole; Erika Cortez; Lais de Carvalho; Ralf Weiskirchen; Simone Carvalho
Journal:  Cells       Date:  2019-10-29       Impact factor: 6.600

View more
  2 in total

Review 1.  Notch-ing up knowledge on molecular mechanisms of skin fibrosis: focus on the multifaceted Notch signalling pathway.

Authors:  Angelo Giuseppe Condorelli; May El Hachem; Giovanna Zambruno; Alexander Nystrom; Eleonora Candi; Daniele Castiglia
Journal:  J Biomed Sci       Date:  2021-05-09       Impact factor: 8.410

2.  MiR-34c promotes hepatic stellate cell activation and Liver Fibrogenesis by suppressing ACSL1 expression.

Authors:  Binbin Li; Jiaxuan Liu; Xuan Xin; Lifen Zhang; Jiaming Zhou; Chunyan Xia; Weijian Zhu; Hongyu Yu
Journal:  Int J Med Sci       Date:  2021-01-01       Impact factor: 3.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.